Qiagen (Pecura business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Qiagen (Pecura business) General Information

Description

Provider of veterinary products distribution services. The company's services include holding of veterinary license for the immunstimulatory cytosine-phosphodiester-guanine (CpG) dinucleotides, presented in synthetic oligodeoxynucleotides (CpG-ODN), which are believed to have promising potential in veterinary applications for livestock and companion animals.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Merial
Primary Office
  • Venlo
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qiagen (Pecura business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qiagen (Pecura business)‘s full profile, request access.

Request a free trial

Qiagen (Pecura business) Executive Team (1)

Name Title Board Seat Contact Info
Rolf Hecker Director
To view Qiagen (Pecura business)’s complete executive team members history, request access »

Qiagen (Pecura business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Qiagen (Pecura business)‘s full profile, request access.

Request a free trial